tiprankstipranks
Trending News
More News >
Parenteral Drugs (India) Limited (IN:PDPL)
:PDPL
India Market

Parenteral Drugs (India) Limited (PDPL) Income Statement

Compare
0 Followers

Parenteral Drugs (India) Limited Income Statement

Last quarter (Q4 2021), Parenteral Drugs (India) Limited's total revenue was ₹17.73M, a decrease of -30.60% from the same quarter last year. In Q4, Parenteral Drugs (India) Limited's net income was ₹238.13M. See Parenteral Drugs (India) Limited’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Mar 22Mar 21Mar 20Mar 19Mar 18
Total Revenue
₹ 84.96M₹ 121.53M₹ 240.25M₹ 319.98M₹ 2.17B
Gross Profit
₹ 30.31M₹ 48.37M₹ 13.40M₹ 75.64M₹ 370.93M
Operating Expenses
₹ 147.87M₹ 338.86M₹ 329.28M₹ 943.42M₹ 796.06M
Depreciation and Amortization
₹ 401.48M₹ 173.26M₹ 173.46M₹ 691.19M₹ 242.43M
EBITDA
₹ 372.69M₹ -117.09M₹ -144.39M₹ -162.40M₹ -12.93M
Operating Income
₹ 0.00₹ -290.99K₹ -320.32K₹ -867.78K₹ -425.13M
Other Income/Expenses
₹ -973.70M₹ -1.54B₹ -1.42B₹ -946.19M₹ -987.37M
Pretax Income
₹ -1.09B₹ -1.54B₹ -1.42B₹ -1.81B₹ -1.41B
Net Income
₹ -763.62M₹ -1.22B₹ -1.14B₹ -1.48B₹ -1.19B
Per Share Metrics
Basic EPS
₹ -25.61₹ -40.82₹ -38.26₹ -49.61₹ -39.89
Diluted EPS
₹ -25.61₹ -40.82₹ -38.26₹ -49.61₹ -39.89
Weighted Average Shares Outstanding
29.82M 29.82M 29.82M 29.82M 29.82M
Weighted Average Shares Outstanding (Diluted)
29.82M 29.82M 29.82M 29.82M 29.82M
Currency in INR

Parenteral Drugs (India) Limited Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis